For stepwise regression analysis, the original model at 24 weeks post-therapy involved post-therapy factors, including sex, age, BMI, HS-CRP, UA, eGFR, ALT, TG, TC, HDL-C, HOMA-IR, platelet, liver cirrhosis, and the rs61330082, rs2302559, rs10953502, and rs2058539 genotypes; the model showed that none of the investigated variables were associated with the post-therapy eNAMPT level in SVR patients. Here, CRP is linked to cirrhosis of liver.